Geistlich Pharma AG
Explore this company’s associated devices, FDA decisions and regulatory history.

Geistlich Pharma AG
- Regulatory records
- 3
- Linked recall entries
- 0
- Headquarters
- Not reported
- Brand website
- Not reported
What the linked records show
MedtechLedger currently links 3 FDA records to the applicant name Geistlich Pharma AG. The collection includes 3 510(k) clearances. These are records held by this publication, rather than a count of the company’s entire portfolio.
The dated entries run from Jan 22, 2026 to Jun 2, 2026. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.
Product code KGN appears in 2 of the 3 linked filings. The collection spans 2 FDA product codes. These figures describe the filings available here; they do not establish the company’s total device sales or market share.
Applicant mailing address recorded by FDA: Bahnhofstrasse 40, Wolhusen, 6110, CH. Recorded on K260364, decision dated Jun 2, 2026.
Device categories in this collection
Filler, Bone Void, Calcium Compound; Wound Dressing With Animal-Derived Material(S).
Subsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.
Regulatory record history
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Device 300419 StripK260364 | Geistlich Pharma AG | 510(k) clearance | Jun 2, 2026 | FDA |
Derma-GideK260532 | Geistlich Pharma AG | 510(k) clearance | Mar 19, 2026 | FDA |
Device 104 ParticulateK251323 | Geistlich Pharma AG | 510(k) clearance | Jan 22, 2026 | FDA |
Source updated Nov 9, 2026. Retrieved Nov 20, 2026.


